<?xml version="1.0" encoding="UTF-8"?>
<xml>
 <records>
  <record>
   <ref-type name="Journal Article">17</ref-type>
   <contributors>
    <authors>
     <author></author>
     <author></author>
     <author></author>
     <author></author>
     <author></author>
     <author></author>
     <author></author>
     <author></author>
     <author></author>
    </authors>
   </contributors>
   <titles>
    <title></title>
   </titles>
   <dates>
    <year>2021</year>
    <pub-dates>
     <date>2021-08-05</date>
    </pub-dates>
   </dates>
   <doi>10.1007/s11094-021-02424-x</doi>
   <abstract>The hypoglycemic activity of glycyrrhizic acid (GA, I), its trisodium (II) and sodium-dilithium salts (III), and a conjugate with L-methionine methyl ester (IV) was studied using an alloxan diabetes model after peroral administration to male Wistar rats. It was found that GA and its conjugate IV at a dose of 100 mg/kg exhibited hypoglycemic activity and reduced the blood glucose content of the animals by 35.5 and 42.6%, respectively, after 120 min. GA conjugate IV had low toxicity and hypoglycemic activity superior to those of GA and acarbose.</abstract>
   <urls>
    <web-urls>
     <url>https://repo.bashgmu.ru/publication/1327</url>
    </web-urls>
    <pdf-urls>
     <url>https://repo.bashgmu.ru/files/1497</url>
    </pdf-urls>
   </urls>
  </record>
 </records>
</xml>
